How does Sceletium work in the brain?

Sceletium contains alkaloids, primarily mesembrine and mesembrenone, that act as serotonin reuptake inhibitors. Mesembrenone also functions as a PDE4 inhibitor, which may enhance its anxiolytic effects. These mechanisms increase serotonin availability in the synaptic cleft, potentially explaining the plant's traditional mood-enhancing and anxiety-relieving properties. Evidence for these mechanisms is rated Level C, based on laboratory and animal studies rather than extensive human trials.

Can I take Sceletium with antidepressants or SSRIs?

No, Sceletium should not be combined with antidepressants or SSRIs. Because Sceletium inhibits serotonin reuptake, combining it with SSRIs or other serotonergic medications significantly increases the risk of serotonin syndrome—a potentially life-threatening condition causing agitation, confusion, rapid heart rate, high blood pressure, and muscle rigidity. This is considered a serious drug interaction. Always consult a healthcare provider before combining Sceletium with any prescription medications.

What is the recommended dosage for Sceletium?

The typical adult dosage is 25–50 mg of standardized extract daily. Traditionally, the San and Khoikhoi peoples chewed fresh plant material, but standardized extracts provide more consistent alkaloid content. Due to limited clinical evidence (Level C), individuals should start at the lower dose and assess tolerance. Consult a qualified healthcare practitioner for personalized dosing, particularly if you have underlying health conditions or take other medications.

Is Sceletium safe during pregnancy or breastfeeding?

No, Sceletium is considered unsafe during pregnancy and breastfeeding. The plant's serotonergic activity and alkaloid content may pose risks to fetal development and infant health through breast milk. There is insufficient safety data to support use during pregnancy or lactation. Pregnant or breastfeeding individuals should avoid Sceletium entirely and consult a healthcare provider for safer alternatives for mood support.

What is Sceletium used for traditionally?

Sceletium has been used for thousands of years by the San and Khoikhoi peoples of South Africa for mood enhancement, anxiety relief, and hunger and thirst suppression during long journeys. It holds sacred significance in Khoisan tradition. Modern interest focuses on potential applications for anxiety and depression, though clinical evidence remains limited (Level C). More rigorous human studies are needed to confirm traditional uses.

Sceletium (Sceletium tortuosum)

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Sceletium tortuosum, commonly known as kanna or kougoed, is a South African medicinal plant used to promote well-being by relieving stress and improving mood [PMID:33924742, PMID:34333104].

Background

Sceletium tortuosum (L.) N.E.Br. is a succulent forb endemic to South Africa [PMID:34333104, PMID:34758918]. It has been used for millennia by the indigenous San and Khoikhoi (Khoisan) peoples [PMID:33924742, PMID:18761074, PMID:38576783].

Traditional uses

Traditionally, the plant was masticated or smoked to relieve toothache, abdominal pain, and to serve as a mood-elevator, analgesic, hypnotic, anxiolytic, thirst and hunger suppressant [PMID:34333104, PMID:34758918]. It was also used for healing, social, and spiritual purposes [PMID:33924742, PMID:18761074].

Active compounds

The primary active constituents are mesembrine-type alkaloids, including mesembrine, mesembrenone, mesembrenol, and mesembranol [PMID:34333104, PMID:35134486]. Hordenine is also identified as a characteristic biomarker [PMID:34750996].

Mechanism of action

Mesembrine acts as a potent inhibitor of the serotonin transporter (SERT) [PMID:31299396, PMID:35134486]. Other reported mechanisms include phosphodiesterase 4 (PDE4) inhibition, monoamine regulation, and antioxidant and anti-inflammatory properties [PMID:40643548]. Some sub-fractions may inhibit acetylcholinesterase (AChE), monoamine oxidase type B (MAO-B), and N-methyl-D-aspartic acid receptor (NMDAR) [PMID:36006974].

Clinical evidence

Evidence BAnxiety (Healthy Volunteers)

A single 25 mg dose of Zembrin® significantly reduced subjective experiences of anxiety and physiological stress indicators (heart rate and galvanic skin response) during a simulated public speaking task [PMID:32761980].

Evidence DDepression and Anxiety (Animal Models)

In rat models, Sceletium tortuosum fractions showed antidepressant properties, though some produced ataxia [PMID:24930358]. Zembrin® and mesembrine reversed anhedonia and anxiety in male rats subjected to chronic mild stress [PMID:40643548].

Evidence DAnxiety (Chick Model)

Alkaloid-enriched fractions at 75 and 100mg/kg decreased distress vocalizations during the anxiety phase [PMID:27553978].

Safety & adverse effects

A 14-day and 90-day repeated oral toxicity study in rats was conducted to assess safety [PMID:25301237]. In rodent models, some fractions associated with antidepressant activity also produced ataxia [PMID:24930358].

Drug interactions

Historical reports indicate a synergism and potentiation when used with smoked Cannabis [PMID:8691846].

Evidence summary

The evidence consists primarily of review articles, in vitro studies, and animal models (rats, chicks, zebrafish), with limited human clinical data from small-scale randomized controlled trials on healthy volunteers.

PubMed sources

1.PMID: 33924742 (2021) — A Chewable Cure "Kanna": Biological and Pharmaceutical Properties of Sceletium tortuosum. · Molecules (Basel, Switzerland)
2.PMID: 34333104 (2021) — Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological and clinical activities. · Journal of ethnopharmacology
3.PMID: 27939420 (2017) — Mesembrine alkaloids: Review of their occurrence, chemistry, and pharmacology. · Journal of ethnopharmacology
4.PMID: 24930358 (2014) — Effects of Sceletium tortuosum in rats. · Journal of ethnopharmacology
5.PMID: 30707215 (2019) — Amaryllidaceae and Sceletium alkaloids. · Natural product reports

Sceletium

Sources & Citations

Albizia

Xiao Yao San Patent

Kemangi Indonesian

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Drug interactions

Evidence summary

PubMed sources

Government sources

Sceletium

Sources & Citations

Related Herbs

Albizia

Xiao Yao San Patent

Kemangi Indonesian

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Drug interactions

Evidence summary

PubMed sources

Government sources